Ding also highlighted that the activation of certain target genes by GLI, namely ABCC1 and transporter associated with antigen processing 1 (TAP 1), are implicated in the drug resistance seen in HCC [66]. This evidence concerns the gene ABCC1 and hepatocellular carcinoma.